Full View

Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review

RE Owens, R Kabra, CS Oliphant - Clinical Cardiology, 2017 - Wiley Online Library
Direct oral anticoagulants (DOACs) are indicated for stroke prevention in patients with
nonvalvular atrial fibrillation (NVAF), which, according to the American College of …
被引用次数：24 相关文章
[HTML] nih.gov

[HTML][HTML] Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review

RE Owens, R Kabra, CS Oliphant - Clinical Cardiology, 2017 - ncbi.nlm.nih.gov
Direct oral anticoagulants (DOACs) are indicated for stroke prevention in patients with
nonvalvular atrial fibrillation (NVAF), which, according to the American College of …

Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review

RE Owens, R Kabra, CS Oliphant - Clinical cardiology, 2017 - pubmed.ncbi.nlm.nih.gov
Direct oral anticoagulants (DOACs) are indicated for stroke prevention in patients with
nonvalvular atrial fibrillation (NVAF), which, according to the American College of …
[PDF] eponline.gr

[PDF][PDF] Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review

RE Owens, R Kabra, CS Oliphant - eponline.gr
Atrial fibrillation (AF) is the most common arrhythmia and confers a substantial stroke risk,
ranging from< 1% to> 20% in the absence of anticoagulation. 1 Stroke prevention is a …

Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.

RE Owens, R Kabra, CS Oliphant - Clinical Cardiology, 2016 - europepmc.org
Direct oral anticoagulants (DOACs) are indicated for stroke prevention in patients with
nonvalvular atrial fibrillation (NVAF), which, according to the American College of …